BRINZOLAMIDE

BRINZOLAMIDE was reported 4322 times

BRINZOLAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEEP ANTERIOR CHAMBER OF THE EYE 4 0.4444
1 URETERIC INJURY 10 0.1176
2 OCULAR PEMPHIGOID 4 0.0952
3 CORNEAL EPITHELIAL MICROCYSTS 2 0.0909
4 PYROGLUTAMATE INCREASED 8 0.0714
5 DEVICE DEPOSIT ISSUE 3 0.0556
6 OPTIC NERVE CUPPING 4 0.0533
7 NORMAL TENSION GLAUCOMA 4 0.0488
8 PUNCTATE KERATITIS 23 0.0484
9 FLAT ANTERIOR CHAMBER OF EYE 7 0.0464
10 INTRAOCULAR PRESSURE DECREASED 15 0.0453
11 INTRAOCULAR PRESSURE FLUCTUATION 6 0.0432
12 OPTIC DISC HAEMORRHAGE 4 0.0417
13 MALIGNANT NEOPLASM OF PLEURA 3 0.0405
14 ENOPHTHALMOS 3 0.0380
15 CILIARY HYPERAEMIA 2 0.0377
16 LENS DISLOCATION 4 0.0374
17 CHOROIDAL DETACHMENT 11 0.0369
18 ANTERIOR CHAMBER FIBRIN 3 0.0323
19 PANCREATIC NECROSIS 10 0.0314
20 EYELASH THICKENING 3 0.0312
21 CORNEAL INFECTION 4 0.0308
22 INTRAOCULAR PRESSURE INCREASED 244 0.0299
23 CILIARY BODY DISORDER 2 0.0294
24 FLOPPY IRIS SYNDROME 9 0.0286
25 INTRAOCULAR PRESSURE TEST ABNORMAL 11 0.0272
26 CORNEAL EPITHELIUM DEFECT 9 0.0271
27 GROWTH OF EYELASHES 17 0.0270
28 CORNEAL EROSION 10 0.0270
29 CORNEAL OEDEMA 33 0.0259
30 GLAUCOMA SURGERY 4 0.0247
31 CONJUNCTIVAL IRRITATION 2 0.0241
32 PRODUCT DROPPER ISSUE 17 0.0239
33 CATARACT CORTICAL 2 0.0227
34 HYPOTONY OF EYE 5 0.0210
35 IRIS ADHESIONS 5 0.0185
36 EYELID MARGIN CRUSTING 19 0.0182
37 IRIS HYPERPIGMENTATION 3 0.0179
38 SCLERAL DISORDER 3 0.0173
39 CORNEAL DISORDER 22 0.0171
40 DENTAL RESTORATION FAILURE 4 0.0169
41 STOMA SITE IRRITATION 3 0.0169
42 CONJUNCTIVITIS ALLERGIC 9 0.0162
43 CONJUNCTIVITIS BACTERIAL 3 0.0155
44 EYE ALLERGY 11 0.0151
45 OPEN ANGLE GLAUCOMA 6 0.0147
46 CONJUNCTIVAL HYPERAEMIA 29 0.0143
47 BODY HEIGHT BELOW NORMAL 6 0.0141
48 GLAUCOMA 161 0.0140
49 CORNEAL OPACITY 10 0.0134
50 HYPHAEMA 4 0.0132
51 CHONDROCALCINOSIS 3 0.0127
52 CORNEAL THINNING 2 0.0123
53 ANTERIOR CHAMBER CELL 3 0.0121
54 URETERAL DISORDER 3 0.0119
55 FOREIGN BODY SENSATION IN EYES 41 0.0119
56 EYE INFECTION BACTERIAL 3 0.0112
57 BLEPHARAL PIGMENTATION 4 0.0111
58 OPTIC NERVE INJURY 7 0.0109
59 CORNEAL DEPOSITS 5 0.0109
60 PRODUCT CONTAINER SEAL ISSUE 5 0.0109
61 BLOOD MAGNESIUM ABNORMAL 3 0.0107
62 OROPHARYNGEAL SPASM 3 0.0106
63 INJURY CORNEAL 3 0.0105
64 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG 3 0.0101
65 EYELID DISORDER 14 0.0100
66 MACULAR FIBROSIS 5 0.0098
67 INTRAOCULAR LENS IMPLANT 3 0.0098
68 OCULAR HYPERTENSION 8 0.0095
69 CONJUNCTIVAL OEDEMA 6 0.0095
70 EYELID PAIN 6 0.0094
71 ACQUIRED HAEMOPHILIA 4 0.0092
72 EYE COLOUR CHANGE 5 0.0088
73 PRODUCT DEPOSIT 5 0.0085
74 PLEUROTHOTONUS 5 0.0084
75 ANTERIOR CHAMBER INFLAMMATION 2 0.0084
76 MACULAR HOLE 7 0.0083
77 ACQUIRED DIAPHRAGMATIC EVENTRATION 2 0.0082
78 RETINAL VASCULAR DISORDER 3 0.0082
79 SCLERAL HYPERAEMIA 5 0.0081
80 GASTRIC NEOPLASM 3 0.0080
81 SWEAT GLAND DISORDER 3 0.0080
82 KERATITIS 13 0.0079
83 CATARACT NUCLEAR 3 0.0079
84 CYSTOID MACULAR OEDEMA 7 0.0078
85 CORNEAL DYSTROPHY 2 0.0078
86 NASAL DISCHARGE DISCOLOURATION 5 0.0078
87 EYE IRRITATION 196 0.0077
88 SUPERFICIAL INJURY OF EYE 4 0.0076
89 SMALL INTESTINAL HAEMORRHAGE 10 0.0075
90 EYE OPERATION 13 0.0074
91 EYELID IRRITATION 8 0.0074
92 RETINAL INJURY 3 0.0072
93 LIQUID PRODUCT PHYSICAL ISSUE 11 0.0072
94 CORNEAL SCAR 2 0.0071
95 BRONCHIAL OBSTRUCTION 6 0.0070
96 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0070
97 VISUAL FIELD DEFECT 35 0.0070
98 EYE DISCHARGE 34 0.0069
99 RETINAL VEIN OCCLUSION 12 0.0069
100 MACULAR OEDEMA 23 0.0068
101 ERYTHEMA OF EYELID 19 0.0067
102 AMAUROSIS FUGAX 3 0.0067
103 REACTION TO PRESERVATIVES 3 0.0066
104 AORTIC DILATATION 4 0.0065
105 COLLAGEN DISORDER 2 0.0065
106 HAEMORRHAGE URINARY TRACT 10 0.0064
107 OPTIC NERVE DISORDER 7 0.0063
108 OCULAR HYPERAEMIA 143 0.0063
109 ULCERATIVE KERATITIS 10 0.0062
110 ESCHAR 3 0.0060
111 FOREIGN BODY IN EYE 3 0.0060
112 EYE PAIN 157 0.0058
113 ACCIDENTAL POISONING 3 0.0058
114 CHOROIDAL EFFUSION 2 0.0058
115 ASPIRATION PLEURAL CAVITY 3 0.0057
116 RETINAL ARTERY OCCLUSION 7 0.0056
117 CORONARY ANGIOPLASTY 2 0.0055
118 VOCAL CORD DISORDER 7 0.0055
119 DACRYOSTENOSIS ACQUIRED 3 0.0054
120 ENDOPHTHALMITIS 17 0.0053
121 BRONCHIAL CARCINOMA 3 0.0052
122 DEAFNESS TRANSITORY 3 0.0051
123 STOMA SITE HAEMORRHAGE 3 0.0051
124 DUODENAL ULCER HAEMORRHAGE 10 0.0050
125 ABNORMAL SENSATION IN EYE 15 0.0050
126 IRIDOCYCLITIS 7 0.0050
127 CORNEAL TRANSPLANT 2 0.0050
128 VITREOUS DETACHMENT 6 0.0049
129 HERPES OPHTHALMIC 3 0.0049
130 CARDIAC INFECTION 2 0.0049
131 OPTIC ATROPHY 5 0.0048
132 OCULAR DISCOMFORT 17 0.0047
133 CARDIAC ANEURYSM 3 0.0047
134 ANGLE CLOSURE GLAUCOMA 8 0.0047
135 CHROMATOPSIA 3 0.0047
136 EYE PRURITUS 63 0.0047
137 VENOUS OCCLUSION 6 0.0047
138 STOMA SITE ERYTHEMA 3 0.0047
139 TOOTH INJURY 5 0.0046
140 EFFUSION 4 0.0046
141 VISUAL ACUITY REDUCED 125 0.0045
142 METAMORPHOPSIA 5 0.0045
143 EYE INFLAMMATION 17 0.0045
144 PRODUCT RESIDUE PRESENT 4 0.0045
145 CHIKUNGUNYA VIRUS INFECTION 2 0.0045
146 BLEPHARITIS 8 0.0045
147 CELLULITIS STAPHYLOCOCCAL 2 0.0045
148 IRITIS 8 0.0044
149 PRODUCT PHYSICAL CONSISTENCY ISSUE 7 0.0043
150 BLINDNESS UNILATERAL 37 0.0043
151 EYE INJURY 6 0.0043
152 PRODUCT ADMINISTRATION ERROR 16 0.0042
153 EYELIDS PRURITUS 6 0.0042
154 CATARACT 126 0.0042
155 AXONAL NEUROPATHY 2 0.0040
156 VITREOUS HAEMORRHAGE 7 0.0039
157 SCOTOMA 3 0.0039
158 MALIGNANT PLEURAL EFFUSION 4 0.0039
159 HYPERAESTHESIA 21 0.0038
160 PUPIL FIXED 5 0.0038
161 CARTILAGE ATROPHY 2 0.0038
162 AGE-RELATED MACULAR DEGENERATION 3 0.0037
163 PRODUCT CONTAINER ISSUE 15 0.0037
164 MACULOPATHY 5 0.0036
165 BLINDNESS 79 0.0036
166 DERMAL CYST 5 0.0036
167 EYE INFECTION 19 0.0035
168 CORNEAL ABRASION 3 0.0035
169 NIGHT BLINDNESS 3 0.0035
170 CEREBELLAR INFARCTION 4 0.0035
171 PYELONEPHRITIS ACUTE 4 0.0034
172 COLOUR BLINDNESS 2 0.0034
173 CHONDROCALCINOSIS PYROPHOSPHATE 2 0.0034
174 MEDICATION RESIDUE PRESENT 16 0.0033
175 CARDIAC FAILURE CHRONIC 6 0.0033
176 EAR CONGESTION 5 0.0033
177 BODY MASS INDEX INCREASED 2 0.0033
178 LACRIMATION INCREASED 48 0.0032
179 RETINAL DETACHMENT 17 0.0032
180 UVEITIS 16 0.0031
181 RETINAL OEDEMA 3 0.0031
182 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 2 0.0030
183 CATHETER SITE PAIN 4 0.0030
184 LIP BLISTER 5 0.0030
185 CARDIAC DYSFUNCTION 2 0.0029
186 DRY EYE 55 0.0029
187 RETINAL TEAR 4 0.0029
188 HORDEOLUM 4 0.0028
189 ASTHENOPIA 9 0.0028
190 ALVEOLITIS ALLERGIC 3 0.0028
191 EYELID OEDEMA 26 0.0028
192 PHARYNGEAL ERYTHEMA 4 0.0028
193 HYPERNATRAEMIA 8 0.0028
194 PERIODONTITIS 4 0.0027
195 MACULAR DEGENERATION 17 0.0027
196 BLOOD CHLORIDE INCREASED 3 0.0027
197 BUNION 2 0.0027
198 HALLUCINATIONS, MIXED 6 0.0027
199 BLOOD MAGNESIUM DECREASED 12 0.0027
200 HYPERAEMIA 3 0.0027
201 IMMUNE THROMBOCYTOPENIC PURPURA 7 0.0026
202 HYPOTONIA 18 0.0026
203 SCREAMING 11 0.0026
204 BRONCHIAL HYPERREACTIVITY 2 0.0025
205 CAROTID ARTERY OCCLUSION 6 0.0025
206 VITREOUS FLOATERS 12 0.0025
207 EYE DISORDER 45 0.0025
208 ANTICONVULSANT DRUG LEVEL DECREASED 3 0.0025
209 INSTILLATION SITE PAIN 5 0.0025
210 ACUTE PRERENAL FAILURE 3 0.0025
211 WEIGHT BEARING DIFFICULTY 4 0.0025
212 PRODUCT PACKAGING QUANTITY ISSUE 8 0.0025
213 INCREASED BRONCHIAL SECRETION 3 0.0024
214 EOSINOPHILIC PNEUMONIA 4 0.0024
215 HEPATIC CYST 5 0.0024
216 BRADYCARDIA 75 0.0023
217 CATARACT OPERATION 9 0.0023
218 PNEUMONIA STAPHYLOCOCCAL 3 0.0023
219 CONCOMITANT DISEASE AGGRAVATED 8 0.0023
220 OPTIC ISCHAEMIC NEUROPATHY 4 0.0023
221 BLOOD UREA DECREASED 2 0.0022
222 EPIGASTRIC DISCOMFORT 5 0.0022
223 METABOLIC ENCEPHALOPATHY 4 0.0022
224 NASAL DRYNESS 8 0.0022
225 HYPOPNOEA 4 0.0022
226 ANIMAL BITE 3 0.0021
227 PANCREATITIS ACUTE 28 0.0021
228 STRABISMUS 4 0.0021
229 EYE HAEMORRHAGE 18 0.0021
230 ORTHOSTATIC HYPOTENSION 21 0.0021
231 MYOPIA 3 0.0021
232 CLOSTRIDIUM COLITIS 2 0.0021
233 PHOTOPHOBIA 21 0.0020
234 APNOEA 11 0.0020
235 VISION BLURRED 162 0.0020
236 MUSCLE RIGIDITY 14 0.0020
237 EYE SWELLING 43 0.0020
238 BLADDER NEOPLASM 2 0.0020
239 AORTIC VALVE DISEASE 2 0.0020
240 CARDIAC FIBRILLATION 2 0.0020
241 BRADYPNOEA 2 0.0020
242 UTERINE CANCER 4 0.0020
243 RETINAL HAEMORRHAGE 9 0.0019
244 VISUAL IMPAIRMENT 117 0.0019
245 DIABETIC RETINOPATHY 4 0.0019
246 EYELID PTOSIS 11 0.0019
247 ABSCESS LIMB 4 0.0019
248 MIOSIS 8 0.0018
249 HYPOACUSIS 33 0.0018
250 BLINDNESS TRANSIENT 8 0.0018
251 EAR DISORDER 5 0.0018
252 KETOACIDOSIS 8 0.0018
253 CONJUNCTIVITIS 15 0.0018
254 SCLERODERMA 4 0.0018
255 CARDIOACTIVE DRUG LEVEL INCREASED 2 0.0018
256 PHOTOPSIA 7 0.0018
257 TENDON RUPTURE 15 0.0018
258 RETINAL DISORDER 3 0.0017
259 DYSLIPIDAEMIA 5 0.0017
260 RETINOPATHY 4 0.0017
261 ORGANISING PNEUMONIA 4 0.0017
262 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0017
263 PHLEBITIS 6 0.0017
264 BRONCHOSPASM 16 0.0016
265 SKIN ATROPHY 5 0.0016
266 ONYCHOMADESIS 3 0.0016
267 PRODUCT AVAILABILITY ISSUE 3 0.0016
268 CHOLANGITIS 5 0.0016
269 CARDIAC FLUTTER 6 0.0016
270 PRODUCT PACKAGING ISSUE 7 0.0016
271 PHARYNGEAL DISORDER 3 0.0016
272 PRODUCT USE COMPLAINT 5 0.0016
273 ADENOCARCINOMA 2 0.0015
274 NEPHROGENIC ANAEMIA 4 0.0015
275 VENTRICULAR HYPOKINESIA 3 0.0015
276 BONE DENSITY ABNORMAL 2 0.0015
277 PANCREATIC CARCINOMA METASTATIC 3 0.0015
278 BUNDLE BRANCH BLOCK RIGHT 5 0.0015
279 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0015
280 LEFT VENTRICULAR DYSFUNCTION 6 0.0015
281 BLOOD PARATHYROID HORMONE INCREASED 3 0.0015
282 HAEMOGLOBIN INCREASED 3 0.0015
283 HYPOTHERMIA 9 0.0014
284 ASPHYXIA 6 0.0014
285 RENAL CANCER 6 0.0014
286 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 7 0.0014
287 INCREASED UPPER AIRWAY SECRETION 6 0.0014
288 REACTION TO DRUG EXCIPIENTS 3 0.0014
289 ENCEPHALITIS 5 0.0014
290 LOCALISED OEDEMA 4 0.0013
291 WOUND 14 0.0013
292 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0013
293 CHEST X-RAY ABNORMAL 3 0.0013
294 SKIN HYPERPIGMENTATION 6 0.0013
295 HYPOPHAGIA 18 0.0013
296 HAEMORRHAGIC STROKE 7 0.0013
297 STUPOR 3 0.0013
298 PEMPHIGOID 4 0.0013
299 AORTIC ARTERIOSCLEROSIS 2 0.0013
300 POOR VENOUS ACCESS 5 0.0013
301 FACIAL PARESIS 3 0.0013
302 PERIORBITAL OEDEMA 4 0.0012
303 HYPERCALCAEMIA 9 0.0012
304 EXTRASYSTOLES 6 0.0012
305 INCORRECT DOSAGE ADMINISTERED 3 0.0012
306 HEART RATE DECREASED 22 0.0012
307 BREATH SOUNDS ABNORMAL 3 0.0012
308 DEAFNESS 17 0.0012
309 ABNORMAL LOSS OF WEIGHT 5 0.0012
310 ANTINUCLEAR ANTIBODY POSITIVE 3 0.0012
311 BREATH ODOUR 2 0.0012
312 MELAENA 17 0.0012
313 ACTINIC KERATOSIS 2 0.0012
314 PALLOR 18 0.0012
315 CONJUNCTIVAL HAEMORRHAGE 3 0.0012
316 HAEMORRHAGE INTRACRANIAL 13 0.0012
317 GENERALISED OEDEMA 9 0.0012
318 NAIL DISORDER 5 0.0012
319 FUNGAL INFECTION 22 0.0012
320 HYPOKALAEMIA 31 0.0012
321 MUSCLE HAEMORRHAGE 3 0.0012
322 HEART RATE IRREGULAR 17 0.0012
323 GINGIVAL DISORDER 3 0.0012
324 VENOUS THROMBOSIS 3 0.0012
325 PERIPHERAL ISCHAEMIA 3 0.0011
326 RHINITIS 5 0.0011
327 CAROTID ARTERY STENOSIS 3 0.0011
328 MUSCLE ATROPHY 8 0.0011
329 WHEEZING 30 0.0011
330 COMA SCALE ABNORMAL 2 0.0011
331 BLOOD CREATININE ABNORMAL 2 0.0011
332 URINE ODOUR ABNORMAL 4 0.0011
333 BREAST CANCER RECURRENT 2 0.0011
334 GASTROINTESTINAL MOTILITY DISORDER 3 0.0011
335 CIRCULATORY COLLAPSE 13 0.0011
336 RESPIRATION ABNORMAL 3 0.0011
337 DIPLOPIA 17 0.0011
338 MONOPLEGIA 3 0.0011
339 ASTHMATIC CRISIS 2 0.0011
340 DIVERTICULUM INTESTINAL 3 0.0011
341 MOUTH SWELLING 3 0.0011
342 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0011
343 UNRESPONSIVE TO STIMULI 17 0.0011
344 COMPRESSION FRACTURE 3 0.0011
345 CARDIOGENIC SHOCK 8 0.0011
346 APPLICATION SITE URTICARIA 2 0.0011
347 AGEUSIA 15 0.0011
348 HAEMORRHAGIC ANAEMIA 5 0.0011
349 HYPONATRAEMIA 36 0.0011
350 TIBIA FRACTURE 3 0.0011
351 ACUTE RESPIRATORY FAILURE 10 0.0010
352 CEREBRAL ISCHAEMIA 4 0.0010
353 ATRIAL FIBRILLATION 58 0.0010
354 DIVERTICULUM 6 0.0010
355 SALIVARY HYPERSECRETION 6 0.0010
356 EPISTAXIS 47 0.0010
357 AORTIC VALVE INCOMPETENCE 3 0.0010
358 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0010
359 INFARCTION 5 0.0010
360 SKIN DISCOLOURATION 27 0.0010
361 SUBDURAL HAEMATOMA 10 0.0010
362 EXPIRED DRUG ADMINISTERED 5 0.0010
363 MIDDLE INSOMNIA 11 0.0010
364 LARGE INTESTINE POLYP 4 0.0010
365 FEMORAL NECK FRACTURE 3 0.0010
366 DYSPHONIA 32 0.0010
367 ELECTROCARDIOGRAM ABNORMAL 5 0.0010
368 ULCER 9 0.0010
369 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0010
370 ASTHMA 46 0.0010
371 PNEUMONIA ASPIRATION 14 0.0010
372 TENSION 4 0.0010
373 HAEMOGLOBIN DECREASED 62 0.0010
374 MENTAL STATUS CHANGES 18 0.0010
375 SCAB 6 0.0010
376 THROAT IRRITATION 24 0.0010
377 DRY MOUTH 46 0.0010
378 INTERNATIONAL NORMALISED RATIO INCREASED 23 0.0010
379 PETIT MAL EPILEPSY 3 0.0010
380 ARRHYTHMIA 29 0.0010
381 GRIP STRENGTH DECREASED 3 0.0009
382 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0009
383 SPINAL COMPRESSION FRACTURE 5 0.0009
384 MALNUTRITION 6 0.0009
385 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0009
386 BLOOD UREA INCREASED 12 0.0009
387 MOUTH HAEMORRHAGE 4 0.0009
388 CEREBRAL HAEMATOMA 2 0.0009
389 SCRATCH 4 0.0009
390 CARDIAC FAILURE ACUTE 3 0.0009
391 DEAFNESS UNILATERAL 3 0.0009
392 HAIR GROWTH ABNORMAL 4 0.0009
393 SYNCOPE 56 0.0009
394 ECZEMA 11 0.0009
395 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0009
396 HALLUCINATION, VISUAL 10 0.0009
397 PELVIC FRACTURE 4 0.0009
398 HIATUS HERNIA 8 0.0009
399 JAUNDICE 17 0.0009
400 BLOOD CALCIUM INCREASED 5 0.0009
401 COMMUNICATION DISORDER 2 0.0009
402 CHOKING SENSATION 3 0.0009
403 DYSGEUSIA 42 0.0009
404 C-REACTIVE PROTEIN INCREASED 15 0.0008
405 MADAROSIS 7 0.0008
406 PRODUCT ODOUR ABNORMAL 4 0.0008
407 SNEEZING 10 0.0008
408 PERIPHERAL COLDNESS 7 0.0008
409 THYROID DISORDER 7 0.0008
410 PROSTATE CANCER 9 0.0008
411 DEVICE OCCLUSION 3 0.0008
412 HYPERTHERMIA 4 0.0008
413 EAR PAIN 9 0.0008
414 INTESTINAL HAEMORRHAGE 3 0.0008
415 EPILEPSY 14 0.0008
416 RHINORRHOEA 27 0.0008
417 RENAL PAIN 5 0.0008
418 ORAL CANDIDIASIS 6 0.0008
419 BACTERAEMIA 5 0.0008
420 TRANSFUSION 5 0.0008
421 MULTIPLE ALLERGIES 3 0.0008
422 GINGIVAL PAIN 4 0.0008
423 COAGULOPATHY 9 0.0008
424 PNEUMOTHORAX 7 0.0008
425 GASTRIC CANCER 3 0.0008
426 CARDIAC VALVE DISEASE 3 0.0008
427 FAILURE TO THRIVE 3 0.0008
428 AZOTAEMIA 2 0.0008
429 HEAD DISCOMFORT 7 0.0008
430 BODY HEIGHT DECREASED 6 0.0008
431 PHARYNGITIS 6 0.0008
432 TENDERNESS 5 0.0008
433 HYPOGLYCAEMIA 25 0.0008
434 PRESYNCOPE 11 0.0008
435 CARDIAC PACEMAKER INSERTION 3 0.0008
436 PULMONARY FIBROSIS 8 0.0008
437 NOCTURIA 5 0.0008
438 HYPERCHOLESTEROLAEMIA 4 0.0008
439 CONFUSIONAL STATE 77 0.0008
440 CREATININE RENAL CLEARANCE DECREASED 2 0.0008
441 BLOOD CHOLESTEROL ABNORMAL 2 0.0008
442 DEMENTIA 10 0.0008
443 RED BLOOD CELL COUNT DECREASED 12 0.0008
444 ACUTE KIDNEY INJURY 52 0.0008
445 SEPTIC SHOCK 18 0.0008
446 PULMONARY CONGESTION 6 0.0008
447 MICTURITION URGENCY 5 0.0008
448 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0008
449 SENSATION OF HEAVINESS 3 0.0008
450 TINNITUS 21 0.0008
451 DYSGRAPHIA 3 0.0008
452 VITAMIN D DEFICIENCY 4 0.0007
453 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 24 0.0007
454 RESPIRATORY TRACT CONGESTION 7 0.0007
455 MYDRIASIS 6 0.0007
456 HYPOXIA 14 0.0007
457 ATELECTASIS 5 0.0007
458 CHAPPED LIPS 2 0.0007
459 HYPERSENSITIVITY 74 0.0007
460 GASTRIC ULCER HAEMORRHAGE 3 0.0007
461 LYMPHOMA 6 0.0007
462 SOPOR 6 0.0007
463 TENDON DISORDER 3 0.0007
464 BACTERIAL INFECTION 7 0.0007
465 BLOOD PRESSURE FLUCTUATION 8 0.0007
466 SWELLING 34 0.0007
467 UPPER LIMB FRACTURE 9 0.0007
468 MUSCULAR WEAKNESS 50 0.0007
469 GENERAL PHYSICAL HEALTH DETERIORATION 39 0.0007
470 BLEPHAROSPASM 2 0.0007
471 CANDIDIASIS 3 0.0007
472 URINARY RETENTION 14 0.0007
473 SINUS CONGESTION 6 0.0007
474 BLOOD CREATININE INCREASED 29 0.0007
475 HYPERTENSION 88 0.0007
476 ASTHENIA 160 0.0007
477 OESOPHAGITIS 5 0.0007
478 HYPOKINESIA 6 0.0007
479 GANGRENE 3 0.0007
480 PLATELET COUNT INCREASED 5 0.0007
481 DISABILITY 5 0.0007
482 DRY THROAT 4 0.0007
483 TENDONITIS 7 0.0007
484 ACCIDENTAL EXPOSURE TO PRODUCT 18 0.0007
485 FALL 135 0.0007
486 PAROSMIA 3 0.0007
487 ACUTE CORONARY SYNDROME 4 0.0007
488 THROAT TIGHTNESS 11 0.0007
489 PARALYSIS 6 0.0007
490 HYPERTONIA 3 0.0007
491 EXPIRED PRODUCT ADMINISTERED 12 0.0007
492 ERYTHEMA MULTIFORME 4 0.0007
493 HIP FRACTURE 12 0.0007
494 JOINT INJURY 8 0.0007
495 HEARING IMPAIRED 4 0.0007
496 APATHY 6 0.0007
497 AORTIC DISSECTION 2 0.0007
498 GASTRITIS 11 0.0007
499 SWELLING FACE 26 0.0007
500 FEELING COLD 11 0.0007
501 LUNG INFECTION 11 0.0007
502 DIZZINESS POSTURAL 3 0.0007
503 DYSPNOEA 212 0.0007
504 PSYCHIATRIC SYMPTOM 3 0.0007
505 VISUAL DISTURBANCE 4 0.0007
506 DYSPHAGIA 36 0.0007
507 DUODENAL ULCER 3 0.0006
508 ANEURYSM 2 0.0006
509 MUSCULOSKELETAL CHEST PAIN 6 0.0006
510 TREATMENT FAILURE 13 0.0006
511 SINUS BRADYCARDIA 4 0.0006
512 HYPOAESTHESIA ORAL 6 0.0006
513 HAEMATOCRIT DECREASED 9 0.0006
514 DISTURBANCE IN ATTENTION 22 0.0006
515 RENAL FAILURE ACUTE 28 0.0006
516 ATRIOVENTRICULAR BLOCK 3 0.0006
517 LIVER DISORDER 16 0.0006
518 RESPIRATORY DISORDER 11 0.0006
519 FOOT FRACTURE 7 0.0006
520 TRANSIENT ISCHAEMIC ATTACK 15 0.0006
521 EOSINOPHILIA 6 0.0006
522 FULL BLOOD COUNT DECREASED 6 0.0006
523 BALANCE DISORDER 33 0.0006
524 HICCUPS 3 0.0006
525 AUTOIMMUNE DISORDER 2 0.0006
526 TACHYCARDIA 32 0.0006
527 PHOTOSENSITIVITY REACTION 6 0.0006
528 DRUG INTOLERANCE 25 0.0006
529 APPLICATION SITE DISCOLOURATION 2 0.0006
530 DIABETES MELLITUS 30 0.0006
531 RENAL IMPAIRMENT 26 0.0006
532 LIPASE INCREASED 3 0.0006
533 PHARYNGEAL OEDEMA 9 0.0006
534 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0006
535 VERTIGO 23 0.0006
536 OROPHARYNGEAL PAIN 30 0.0006
537 ANAPHYLACTIC REACTION 17 0.0006
538 BLOOD CHOLESTEROL INCREASED 17 0.0006
539 BOWEL MOVEMENT IRREGULARITY 2 0.0006
540 AGRANULOCYTOSIS 6 0.0006
541 DECREASED ACTIVITY 3 0.0006
542 BLOOD PRESSURE INCREASED 51 0.0006
543 RESPIRATORY TRACT INFECTION 8 0.0006
544 BENIGN PROSTATIC HYPERPLASIA 2 0.0006
545 PALPITATIONS 42 0.0006
546 LOSS OF CONSCIOUSNESS 48 0.0006
547 JOINT SWELLING 34 0.0006
548 BREAST CANCER FEMALE 9 0.0006
549 VITAMIN D DECREASED 3 0.0006
550 MYALGIA 62 0.0006
551 LUNG NEOPLASM MALIGNANT 9 0.0006
552 MASS 5 0.0006
553 SOMNOLENCE 69 0.0006
554 DYSSTASIA 10 0.0006
555 PRODUCT TASTE ABNORMAL 4 0.0006
556 MULTIPLE MYELOMA 3 0.0006
557 LUNG DISORDER 15 0.0006
558 HYPERKALAEMIA 12 0.0006
559 LETHARGY 21 0.0006
560 TUBULOINTERSTITIAL NEPHRITIS 6 0.0006
561 FIBROMYALGIA 7 0.0006
562 NASOPHARYNGITIS 55 0.0006
563 DYSPEPSIA 32 0.0006
564 HAEMORRHOIDS 7 0.0006
565 BRONCHOPNEUMONIA 2 0.0006
566 HYPOTENSION 65 0.0006
567 BLOOD PRESSURE DECREASED 22 0.0006
568 BLOOD POTASSIUM DECREASED 10 0.0006
569 ANGINA PECTORIS 11 0.0006
570 ARTERIAL OCCLUSIVE DISEASE 3 0.0006
571 SQUAMOUS CELL CARCINOMA 3 0.0006
572 TOXIC EPIDERMAL NECROLYSIS 5 0.0006
573 CHRONIC KIDNEY DISEASE 23 0.0006
574 CHEST DISCOMFORT 31 0.0006
575 STENT PLACEMENT 3 0.0005
576 HAEMATEMESIS 9 0.0005
577 PRODUCT QUALITY ISSUE 56 0.0005
578 METASTASES TO LIVER 5 0.0005
579 HEAD INJURY 10 0.0005
580 SEASONAL ALLERGY 3 0.0005
581 HEMIPLEGIA 3 0.0005
582 PRURITUS GENERALISED 12 0.0005
583 URINARY INCONTINENCE 10 0.0005
584 RECTAL HAEMORRHAGE 15 0.0005
585 RENAL DISORDER 14 0.0005
586 SPINAL PAIN 3 0.0005
587 ANAEMIA 64 0.0005
588 GLOSSODYNIA 5 0.0005
589 CARDIOMEGALY 5 0.0005
590 EAR DISCOMFORT 3 0.0005
591 CONDITION AGGRAVATED 68 0.0005
592 BLOOD SODIUM DECREASED 6 0.0005
593 PULMONARY ARTERIAL HYPERTENSION 5 0.0005
594 END STAGE RENAL DISEASE 6 0.0005
595 CONTUSION 29 0.0005
596 DYSURIA 12 0.0005
597 SPEECH DISORDER 17 0.0005
598 LIMB INJURY 7 0.0005
599 SHOCK 7 0.0005
600 THIRST 5 0.0005
601 CEREBRAL HAEMORRHAGE 12 0.0005
602 NIGHTMARE 12 0.0005
603 RIB FRACTURE 6 0.0005
604 HAEMOPTYSIS 9 0.0005
605 DRUG INEFFECTIVE 347 0.0005
606 IMPAIRED DRIVING ABILITY 4 0.0005
607 FAECES DISCOLOURED 7 0.0005
608 GASTROINTESTINAL HAEMORRHAGE 33 0.0005
609 CORONARY ARTERY DISEASE 13 0.0005
610 NASAL CONGESTION 15 0.0005
611 COUGH 75 0.0005
612 FOOT DEFORMITY 3 0.0005
613 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0005
614 DIZZINESS 150 0.0005
615 FEMUR FRACTURE 11 0.0005
616 LIP SWELLING 10 0.0005
617 DERMATITIS 5 0.0005
618 BLADDER DISORDER 3 0.0005
619 MUSCULOSKELETAL STIFFNESS 23 0.0005
620 SEIZURE 24 0.0005
621 THROMBOSIS 23 0.0005
622 BLOOD URINE PRESENT 6 0.0005
623 FEAR 10 0.0005
624 DRUG HYPERSENSITIVITY 57 0.0005
625 ACCIDENT 3 0.0005
626 SWOLLEN TONGUE 10 0.0005
627 BLOOD COUNT ABNORMAL 5 0.0005
628 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0005
629 GAIT DISTURBANCE 56 0.0005
630 GOUT 5 0.0005
631 OSTEOMYELITIS 6 0.0005
632 BLOOD GLUCOSE DECREASED 16 0.0005
633 PANIC ATTACK 11 0.0005
634 DYSPNOEA EXERTIONAL 9 0.0005
635 DRUG INTERACTION 46 0.0005
636 SUBARACHNOID HAEMORRHAGE 3 0.0005
637 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0005
638 CORONARY ARTERY OCCLUSION 5 0.0005
639 BREAST MASS 2 0.0005
640 CARDIAC DISORDER 27 0.0005
641 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0005
642 EXTRAPYRAMIDAL DISORDER 10 0.0005
643 MUSCLE TIGHTNESS 5 0.0005
644 RASH PAPULAR 7 0.0005
645 CYANOSIS 5 0.0005
646 RASH PRURITIC 14 0.0005
647 SLEEP DISORDER 16 0.0005
648 PLEURAL EFFUSION 18 0.0005
649 INCORRECT DOSE ADMINISTERED 41 0.0005
650 GASTROOESOPHAGEAL REFLUX DISEASE 22 0.0005
651 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0005
652 PETECHIAE 3 0.0005
653 BLISTER 14 0.0005
654 SKIN ULCER 7 0.0005
655 COORDINATION ABNORMAL 5 0.0005
656 MUSCULOSKELETAL PAIN 19 0.0005
657 MALAISE 130 0.0005
658 NECK PAIN 15 0.0005
659 PAIN IN EXTREMITY 85 0.0005
660 GASTRIC DISORDER 11 0.0005
661 OEDEMA PERIPHERAL 40 0.0005
662 NO ADVERSE EVENT 32 0.0005
663 VASCULITIS 3 0.0005
664 CARDIAC MURMUR 3 0.0005
665 PRESCRIBED OVERDOSE 5 0.0005
666 DRUG DISPENSING ERROR 7 0.0005
667 DRUG ADMINISTRATION ERROR 14 0.0005
668 HEPATIC STEATOSIS 5 0.0005
669 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0004
670 MYOCARDIAL ISCHAEMIA 4 0.0004
671 PRODUCT SUBSTITUTION ISSUE 15 0.0004
672 DISEASE RECURRENCE 6 0.0004
673 EMPHYSEMA 3 0.0004
674 SEXUAL DYSFUNCTION 3 0.0004
675 PRODUCT DOSE OMISSION 18 0.0004
676 HEADACHE 166 0.0004
677 DIARRHOEA 148 0.0004
678 DISORIENTATION 12 0.0004
679 ABDOMINAL DISCOMFORT 37 0.0004
680 NERVOUSNESS 16 0.0004
681 URINARY TRACT INFECTION 40 0.0004
682 BONE DENSITY DECREASED 3 0.0004
683 HEMIPARESIS 5 0.0004
684 BLOOD PRESSURE ABNORMAL 4 0.0004
685 WRIST FRACTURE 3 0.0004
686 RENAL INJURY 7 0.0004
687 NEOPLASM MALIGNANT 12 0.0004
688 CEREBRAL INFARCTION 7 0.0004
689 INTERSTITIAL LUNG DISEASE 11 0.0004
690 HYPERTENSIVE CRISIS 3 0.0004
691 ANGER 10 0.0004
692 AFFECT LABILITY 3 0.0004
693 HEPATOMEGALY 3 0.0004
694 FRACTURE 4 0.0004
695 HAIR TEXTURE ABNORMAL 4 0.0004
696 CARDIAC FAILURE CONGESTIVE 28 0.0004
697 LOWER RESPIRATORY TRACT INFECTION 9 0.0004
698 FREQUENT BOWEL MOVEMENTS 5 0.0004
699 CHEST PAIN 52 0.0004
700 CELLULITIS 13 0.0004
701 HAEMATOCHEZIA 11 0.0004
702 METABOLIC ACIDOSIS 7 0.0004
703 LACERATION 4 0.0004
704 HALLUCINATION 17 0.0004
705 AMNESIA 18 0.0004
706 ELECTROCARDIOGRAM QT PROLONGED 8 0.0004
707 FATIGUE 172 0.0004
708 BREAST PAIN 3 0.0004
709 SKIN DISORDER 7 0.0004
710 PRODUCT STORAGE ERROR 6 0.0004
711 ERUCTATION 4 0.0004
712 ERYTHEMA 47 0.0004
713 CARDIOMYOPATHY 4 0.0004
714 APHAGIA 2 0.0004
715 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0004
716 BURNING SENSATION 18 0.0004
717 CYSTITIS 8 0.0004
718 DRUG ERUPTION 4 0.0004
719 TACHYPNOEA 3 0.0004
720 CARDIAC FAILURE 19 0.0004
721 PRODUCTIVE COUGH 9 0.0004
722 SINUSITIS 23 0.0004
723 HAEMATOMA 7 0.0004
724 MUSCULOSKELETAL DISCOMFORT 4 0.0004
725 PNEUMONIA 74 0.0004
726 OXYGEN SATURATION DECREASED 10 0.0004
727 GASTRIC ULCER 5 0.0004
728 PROTEINURIA 4 0.0004
729 NIGHT SWEATS 7 0.0004
730 DEHYDRATION 34 0.0004
731 POLLAKIURIA 10 0.0004
732 PULMONARY OEDEMA 11 0.0004
733 BODY TEMPERATURE INCREASED 5 0.0004
734 PERIPHERAL SWELLING 27 0.0004
735 DYSKINESIA 10 0.0004
736 NEURALGIA 5 0.0004
737 HEPATITIS 6 0.0004
738 BRONCHITIS 19 0.0004
739 FLATULENCE 13 0.0004
740 MOBILITY DECREASED 15 0.0004
741 BONE PAIN 14 0.0004
742 COLITIS 7 0.0004
743 VENTRICULAR FIBRILLATION 3 0.0004
744 BLOOD IRON DECREASED 2 0.0004
745 ABDOMINAL PAIN UPPER 45 0.0004
746 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 28 0.0004
747 HOT FLUSH 15 0.0004
748 BACK PAIN 53 0.0004
749 HEART RATE INCREASED 22 0.0004
750 PAIN IN JAW 7 0.0004
751 SCAR 4 0.0004
752 ARTHRITIS 16 0.0004
753 PAIN 117 0.0004
754 PERICARDIAL EFFUSION 5 0.0004
755 FEELING HOT 14 0.0004
756 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0004
757 POST PROCEDURAL HAEMORRHAGE 3 0.0004
758 NEPHROLITHIASIS 9 0.0004
759 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0004
760 ATAXIA 3 0.0004
761 COMA 11 0.0004
762 RENAL FAILURE CHRONIC 3 0.0004
763 INCORRECT PRODUCT STORAGE 5 0.0004
764 SPINAL FRACTURE 4 0.0004
765 BLOOD GLUCOSE ABNORMAL 4 0.0004
766 ABDOMINAL PAIN LOWER 6 0.0004
767 GINGIVAL BLEEDING 3 0.0004
768 RASH GENERALISED 10 0.0004
769 KIDNEY INFECTION 4 0.0004
770 TOOTH EXTRACTION 3 0.0004
771 BLOOD ALBUMIN DECREASED 2 0.0004
772 PARAESTHESIA ORAL 3 0.0004
773 OEDEMA 12 0.0004
774 HAIR COLOUR CHANGES 3 0.0004
775 HYPOTHYROIDISM 6 0.0004
776 CEREBROVASCULAR ACCIDENT 42 0.0004
777 CARPAL TUNNEL SYNDROME 3 0.0004
778 TREMOR 38 0.0004
779 SEDATION 5 0.0004
780 CHOKING 4 0.0004
781 CONSTIPATION 41 0.0004
782 HYPERGLYCAEMIA 8 0.0004
783 INTERVERTEBRAL DISC PROTRUSION 5 0.0004
784 MOVEMENT DISORDER 7 0.0004
785 ARTHRALGIA 76 0.0004
786 THROMBOCYTOPENIA 22 0.0004
787 RENAL FAILURE 30 0.0004
788 STOMATITIS 11 0.0003
789 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0003
790 SLEEP APNOEA SYNDROME 4 0.0003
791 SKIN LESION 5 0.0003
792 ALOPECIA 39 0.0003
793 ACCIDENTAL OVERDOSE 7 0.0003
794 CHROMATURIA 5 0.0003
795 NEOPLASM PROGRESSION 5 0.0003
796 PRESCRIBED UNDERDOSE 3 0.0003
797 RASH ERYTHEMATOUS 8 0.0003
798 ABDOMINAL PAIN 47 0.0003
799 ANKLE FRACTURE 3 0.0003
800 HYPERLIPIDAEMIA 3 0.0003
801 DYSARTHRIA 8 0.0003
802 PYREXIA 68 0.0003
803 DISEASE PROGRESSION 19 0.0003
804 PRURITUS 58 0.0003
805 ANURIA 2 0.0003
806 DRUG LEVEL INCREASED 3 0.0003
807 VIRAL INFECTION 6 0.0003
808 ARTHROPATHY 9 0.0003
809 LACTIC ACIDOSIS 5 0.0003
810 CHILLS 22 0.0003
811 DISCOMFORT 8 0.0003
812 APHASIA 6 0.0003
813 FEELING ABNORMAL 48 0.0003
814 OFF LABEL USE 98 0.0003
815 MEMORY IMPAIRMENT 25 0.0003
816 ABASIA 8 0.0003
817 STAPHYLOCOCCAL INFECTION 7 0.0003
818 CHOLELITHIASIS 7 0.0003
819 WHITE BLOOD CELL COUNT INCREASED 8 0.0003
820 LIMB DISCOMFORT 5 0.0003
821 PANCYTOPENIA 10 0.0003
822 TRANSAMINASES INCREASED 4 0.0003
823 CRYING 8 0.0003
824 MUSCLE SPASMS 35 0.0003
825 DECREASED APPETITE 38 0.0003
826 HYPOAESTHESIA 28 0.0003
827 OSTEOPOROSIS 6 0.0003
828 MYOCARDIAL INFARCTION 42 0.0003
829 BONE MARROW FAILURE 5 0.0003
830 DEPRESSION 46 0.0003
831 INFLAMMATION 7 0.0003
832 BLOOD GLUCOSE INCREASED 38 0.0003
833 WHITE BLOOD CELL COUNT DECREASED 17 0.0003
834 HERNIA 3 0.0003
835 BLADDER CANCER 4 0.0003
836 ORAL PAIN 4 0.0003
837 MEDICATION ERROR 11 0.0003
838 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0003
839 FLUID RETENTION 9 0.0003
840 MOOD ALTERED 5 0.0003
841 TOOTH DISORDER 4 0.0003
842 PULMONARY HYPERTENSION 4 0.0003
843 GASTROENTERITIS VIRAL 3 0.0003
844 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0003
845 VOMITING 79 0.0003
846 NEUROPATHY PERIPHERAL 13 0.0003
847 RESPIRATORY DISTRESS 5 0.0003
848 CHOLESTASIS 3 0.0003
849 IRRITABLE BOWEL SYNDROME 3 0.0003
850 BLOOD CALCIUM DECREASED 2 0.0003
851 INTENTIONAL DRUG MISUSE 6 0.0003
852 LEUKOPENIA 8 0.0003
853 CHOLECYSTECTOMY 2 0.0003
854 PARAESTHESIA 27 0.0003
855 ALANINE AMINOTRANSFERASE INCREASED 11 0.0003
856 APHONIA 2 0.0003
857 BLOOD BILIRUBIN INCREASED 5 0.0003
858 COGNITIVE DISORDER 7 0.0003
859 MENTAL IMPAIRMENT 4 0.0003
860 RESTLESS LEGS SYNDROME 3 0.0003
861 RASH 60 0.0003
862 INJECTION SITE HAEMORRHAGE 11 0.0003
863 INSOMNIA 45 0.0003
864 COLD SWEAT 3 0.0003
865 PRODUCT USE ISSUE 24 0.0003
866 ABDOMINAL DISTENSION 16 0.0003
867 THERAPEUTIC RESPONSE DECREASED 9 0.0003
868 FACE OEDEMA 3 0.0003
869 HAEMATURIA 6 0.0003
870 DRUG-INDUCED LIVER INJURY 3 0.0003
871 ADVERSE REACTION 2 0.0003
872 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0003
873 UPPER RESPIRATORY TRACT INFECTION 7 0.0003
874 CHOLECYSTITIS 2 0.0003
875 ABNORMAL BEHAVIOUR 8 0.0003
876 DIVERTICULITIS 4 0.0003
877 HYPERHIDROSIS 21 0.0003
878 AGGRESSION 9 0.0003
879 CARDIAC ARREST 14 0.0003
880 DRUG PRESCRIBING ERROR 5 0.0003
881 POOR QUALITY SLEEP 3 0.0003
882 SEPSIS 17 0.0003
883 TOXICITY TO VARIOUS AGENTS 22 0.0003
884 STEVENS-JOHNSON SYNDROME 4 0.0003
885 HERPES ZOSTER 8 0.0003
886 ANXIETY 44 0.0003
887 NAUSEA 118 0.0003
888 ECONOMIC PROBLEM 3 0.0003
889 HEPATIC FUNCTION ABNORMAL 5 0.0002
890 WEIGHT DECREASED 40 0.0002
891 HAEMORRHAGE 15 0.0002
892 BEDRIDDEN 2 0.0002
893 LYMPHADENOPATHY 5 0.0002
894 DEPRESSED MOOD 7 0.0002
895 GALLBLADDER DISORDER 3 0.0002
896 ACUTE MYOCARDIAL INFARCTION 5 0.0002
897 EATING DISORDER 3 0.0002
898 INFECTION 17 0.0002
899 PNEUMONITIS 3 0.0002
900 INTENTIONAL PRODUCT USE ISSUE 5 0.0002
901 GASTROINTESTINAL DISORDER 9 0.0002
902 PANCREATITIS 8 0.0002
903 DEEP VEIN THROMBOSIS 11 0.0002
904 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0002
905 LOCAL SWELLING 4 0.0002
906 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
907 NEUTROPENIA 14 0.0002
908 LOCALISED INFECTION 3 0.0002
909 ENCEPHALOPATHY 3 0.0002
910 OVERDOSE 21 0.0002
911 IRRITABILITY 9 0.0002
912 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0002
913 OSTEONECROSIS OF JAW 4 0.0002
914 INJECTION SITE PAIN 34 0.0002
915 FEBRILE NEUTROPENIA 7 0.0002
916 ANAPHYLACTIC SHOCK 3 0.0002
917 MENTAL DISORDER 5 0.0002
918 OSTEONECROSIS 4 0.0002
919 PLATELET COUNT DECREASED 12 0.0002
920 BREAST CANCER 7 0.0002
921 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 16 0.0002
922 MIGRAINE 10 0.0002
923 BACK DISORDER 2 0.0002
924 CARDIO-RESPIRATORY ARREST 6 0.0002
925 THERAPY NON-RESPONDER 3 0.0002
926 DEVICE ISSUE 6 0.0002
927 WEIGHT INCREASED 25 0.0002
928 INJECTION SITE BRUISING 9 0.0002
929 JOINT STIFFNESS 3 0.0002
930 APPLICATION SITE RASH 2 0.0002
931 ANGIOEDEMA 5 0.0002
932 BLOOD POTASSIUM INCREASED 2 0.0002
933 DRY SKIN 11 0.0002
934 ILL-DEFINED DISORDER 4 0.0002
935 COLITIS ULCERATIVE 3 0.0002
936 INFLUENZA 11 0.0002
937 RESPIRATORY ARREST 4 0.0002
938 SKIN BURNING SENSATION 7 0.0002
939 RHABDOMYOLYSIS 5 0.0002
940 INFUSION RELATED REACTION 5 0.0002
941 DRUG EFFECT INCOMPLETE 7 0.0002
942 STRESS 7 0.0002
943 URTICARIA 17 0.0002
944 HYPERSOMNIA 3 0.0002
945 PULMONARY EMBOLISM 12 0.0002
946 LABORATORY TEST ABNORMAL 3 0.0002
947 SKIN IRRITATION 4 0.0002
948 INJURY 9 0.0002
949 TYPE 2 DIABETES MELLITUS 4 0.0002
950 PRODUCT USE IN UNAPPROVED INDICATION 12 0.0002
951 AGITATION 9 0.0002
952 SKIN EXFOLIATION 7 0.0002
953 THERAPY CESSATION 4 0.0002
954 HEPATIC ENZYME INCREASED 6 0.0002
955 INFLUENZA LIKE ILLNESS 10 0.0002
956 RESTLESSNESS 4 0.0002
957 ALTERED STATE OF CONSCIOUSNESS 2 0.0002
958 UNDERDOSE 7 0.0002
959 RHEUMATOID ARTHRITIS 9 0.0002
960 INTENTIONAL PRODUCT MISUSE 8 0.0002
961 RASH MACULAR 3 0.0002
962 INJECTION SITE MASS 3 0.0002
963 WRONG TECHNIQUE IN DRUG USAGE PROCESS 6 0.0002
964 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0002
965 DEATH 73 0.0002
966 NEUTROPHIL COUNT DECREASED 3 0.0002
967 PSYCHOTIC DISORDER 3 0.0002
968 RESPIRATORY FAILURE 7 0.0002
969 HEPATIC FAILURE 3 0.0002
970 ANOREXIA 2 0.0001
971 DRUG EFFECT DECREASED 8 0.0001
972 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
973 CARDIOVASCULAR DISORDER 3 0.0001
974 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
975 CONVULSION 8 0.0001
976 LIVER FUNCTION TEST ABNORMAL 3 0.0001
977 FLUSHING 9 0.0001
978 HOSPITALISATION 8 0.0001
979 ADVERSE EVENT 7 0.0001
980 EMOTIONAL DISTRESS 5 0.0001
981 PSORIASIS 8 0.0001
982 SUICIDAL IDEATION 7 0.0001
983 DEVICE MALFUNCTION 3 0.0001
984 DRUG DOSE OMISSION 19 0.0001
985 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
986 ASCITES 2 0.0001
987 UNEVALUABLE EVENT 5 0.0001
988 ADVERSE DRUG REACTION 4 0.0001
989 MULTIPLE SCLEROSIS 3 0.0001
990 ACNE 4 0.0001
991 INJECTION SITE ERYTHEMA 8 0.0001
992 INJECTION SITE PRURITUS 4 0.0001
993 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
994 MULTIPLE SCLEROSIS RELAPSE 4 0.0001